Literature DB >> 20132332

Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies.

M Carcao1, H Chambost, R Ljung.   

Abstract

Data from prospective studies clearly demonstrate the efficacy of prophylactic treatment of haemophilia in reducing joint- or life-threatening bleeding and the associated consequences for quality of life. Debate remains, however, regarding the optimal implementation of prophylaxis. Our aim in this review was to identify a best practice approach to factor replacement prophylaxis in boys with haemophilia. We evaluate prophylactic treatment regimens currently used in Swedish, Canadian and French centres and highlight key issues, including the optimal age for starting prophylaxis, the optimal treatment dosage/schedule and patient compliance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132332     DOI: 10.1111/j.1365-2516.2009.02196.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  3 in total

1.  Target of prophylaxis in severe haemophilia: more than factor levels.

Authors:  Antonio Coppola; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

Review 2.  The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.

Authors:  Hector E Castro; María Fernanda Briceño; Claudia P Casas; Juan David Rueda
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-04       Impact factor: 0.900

3.  Sucrose-Formulated Recombinant Factor VIII Dosing Flexibility in Prophylaxis Regimens: Experience from Postmarketing Surveillance Studies.

Authors:  Thomas J Humphries; Stephan Rauchensteiner; Claudia Tückmantel; Alexander Pieper; Monika Maas Enriquez; Prasad Mathew
Journal:  Adv Hematol       Date:  2015-08-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.